Lipella Pharmaceuticals Inc. (LIPO): Shareholders' Equity
Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$1.92M
As of 2024-12-31
$1.49M
As of 2025-09-30
+10.5%
3-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $1.92M | -39.0% | 2025-03-28, Balance as of period end |
| 2023-12-31 | $3.14M | -32.7% | 2025-03-28, Balance as of period end |
| 2022-12-31 | $4.68M | +228.4% | 2024-02-27, Balance as of period end |
| 2021-12-31 | $1.42M | n/a | 2023-03-31, Balance as of period end |